Chinese biopharma firm Abbisko closes $70m Series C round led by Temasek

Chinese biopharma firm Abbisko closes $70m Series C round led by Temasek

Source: Laurynas Mereckas/Unsplash

25 March, 2020

Abbisko Therapeutics biopharmaceutical Temasek

Printed by Unregistered user on Sat, 12 Jul 2025 06:10:31 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Asian healthcare investment booms, offers ‘double bottom line’ for private equity

China's CDH Investments eyes growth in consumer healthcare sector

Read more from Greater China

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies

Policy & Regulations

China’s Chery, BYD may have to repay subsidies after audit finds improper claims